[Patients with prostate cancer after radical prostatectomy: Stage migration and changes in tumor characteristics from 1998-2012]
- PMID: 26471796
- DOI: 10.1007/s00120-015-3988-8
[Patients with prostate cancer after radical prostatectomy: Stage migration and changes in tumor characteristics from 1998-2012]
Abstract
Background: The aim of this study was to verify the described inverse stage migration after radical prostatectomy by a tertiary care center in 2011 in a national collective.
Materials and methods: Data from 10,323 patients with prostate cancer (PCa), who had radical prostatectomy between 1998 and 2012, were analyzed regarding prostate-specific antigen (PSA) and age at diagnosis, T stage, and Gleason score. A trend over time was determined by using the Jonckheere-Terpstra test.
Results: Median age at surgery was 65 years (1998: 63.7; 2012: 66.5). The proportion of low-risk tumors decreased from 39% in 2005 to 25% in 2012, while the intermediate-risk tumors showed a continuous increase since 1998 from 35 to 52% in 2012. The proportion of patients with a Gleason score ≤ 6 decreased from 60% in 1998 to 25 % in 2012. The Gleason score groups 7a and 7b, however, increased from 12 to 46, % and 12 to 19%, respectively. The proportion of tumors with a Gleason score of 8-10 decreased from 16 to 10%. The proportion of organ-confined prostate cancer increased from 1998 to 2007 continuously from 57 to 73%. Since 2007 the proportion dropped to 64%.
Conclusions: In this national population a trend towards inverse stage migration can be noted. Both the increase in Gleason score ≥ 6 and intermediate-risk tumors can be explained by the modification of the Gleason score. The tendency towards higher age and nonorgan-confined cancers at surgery could be dependent of the growing recognition of radical prostatectomy as a treatment for locally advanced prostate cancer, on the one hand, and the increase of alternative treatments for low-risk cancers, on the other hand.
Keywords: Gleason Score; Jonckheere-Terpstra Test; Lymph node staging; Neoplasm staging; Prostate-specific antigen.
Similar articles
-
Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.J Urol. 2000 Aug;164(2):411-5. J Urol. 2000. PMID: 10893598 Clinical Trial.
-
Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.J Urol. 2001 Mar;165(3):851-6. J Urol. 2001. PMID: 11176485
-
Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.J Urol. 2002 Jul;168(1):110-5. J Urol. 2002. PMID: 12050502
-
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4. BJU Int. 2013. PMID: 22487441
-
Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.J Urol. 1997 Jun;157(6):2206-9. J Urol. 1997. PMID: 9146616 Free PMC article. Review.
Cited by
-
[Radical prostatectomy in locally advanced prostate cancer].Urologe A. 2017 Nov;56(11):1394-1401. doi: 10.1007/s00120-017-0512-3. Urologe A. 2017. PMID: 28983643 Review. German.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous